| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
276 |
248 |
$14K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
182 |
85 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
34 |
32 |
$992.64 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
219 |
162 |
$752.22 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
20 |
20 |
$211.28 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
43 |
37 |
$66.88 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
31 |
27 |
$18.86 |
| 1159F |
|
335 |
297 |
$0.00 |
| 1160F |
|
319 |
283 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
113 |
93 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
323 |
261 |
$0.00 |
| 3008F |
|
75 |
68 |
$0.00 |